OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
KRYS holding history
Krystal Biotech, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 83,200
- Value
- $30.9M
- % of portfolio
- 0.6%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 83,200 | $30.9M | 0.6% | +14,100+20.4% | Added | Holders |
| Q1 2026 | 69,100 | $17.8M | 0.4% | −50,700−42.3% | Reduced | Holders |
| Q4 2025 | 119,800 | $29.5M | 0.6% | +17,055+16.6% | Added | Holders |
| Q3 2025 | 102,745 | $18.1M | 0.4% | +93,545+1,016.8% | Added | Holders |
| Q2 2025 | 9,200 | $1.26M | <0.1% | −14,300−60.9% | Reduced | Holders |
| Q1 2025 | 23,500 | $4.24M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 23,500 | $3.68M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 23,500 | $4.28M | 0.1% | −6,466−21.6% | Reduced | Holders |
| Q2 2024 | 29,966 | $5.50M | 0.1% | −7,200−19.4% | Reduced | Holders |
| Q1 2024 | 37,166 | $6.61M | 0.1% | −66,534−64.2% | Reduced | Holders |
| Q4 2023 | 103,700 | $12.9M | 0.3% | +103,700 | New | Holders |